Screener
Kiniksa Pharmaceuticals International, plc KNSA Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 89.8%+3.9pp | 89.3%+3.5pp | 88.5%+2.9pp | 87.5%+1.2pp | 85.9%-1.8pp | |
| Operating margin | 11.9%+11.1pp | 12.4%+15.6pp | 11.4%+22.2pp | 6.4%+13.2pp | 0.8%+9.0pp | |
| Net margin | 9.6%+8.7pp | 9.7%+13.2pp | 8.7%+18.9pp | 6%+8.4pp | 0.9%+3.9pp | |
| Returns | ||||||
| Return on equity | 14%+13.0pp | 13.7%+17.6pp | 11.7%+21.6pp | 7.4%+9.5pp | 1%+3.4pp | |
| Return on invested capital | 17.7%+16.3pp | 17.5%+22.6pp | 15.2%+30.2pp | 10.6%+18.7pp | 1.4%+9.7pp | |
| Efficiency | ||||||
| Asset turnover | 1.1×+0.2× | 1.1×+0.2× | 1×+0.2× | 0.9×+0.2× | 0.9×+0.2× | |
| Liquidity | ||||||
| Current ratio | 3.9×+0.3× | 3.8×+0.1× | 3.8×+0.5× | 3.8×+0.6× | 3.6×0.0× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Net debt / EBITDA | -1.6×+28.9× | -1.9×— | -2×— | -4.2×— | -30.5×— | |
| Per Share | ||||||
| Book value per share | $7.84+23.5% | $7.35+22.3% | $7.19+17.1% | $6.69+9.8% | $6.35+3.6% | |
| Valuation | ||||||
| Market capitalization | $5.73B+135% | $3.69B+128% | $3.13B+119% | $2.88B+62.2% | $2.12B+60.8% | |
| Price / earnings | 71×-439× | 50.4×— | 53×— | 80.1×— | 442.7×— | |
| Price / sales | 6.8×+2.2× | 4.9×+1.5× | 4.6×+1.2× | 4.8×+0.2× | 4×+0.1× | |
| Price / book | 8.8×+3.8× | 6.1×+2.6× | 5.5×+2.3× | 5.4×+1.3× | 4.3×+1.3× | |
| EV / EBITDA | 54.5×-324× | 36.9×— | 37.7×— | 68.4×— | 324.3×— |
FAQ
- What are Kiniksa Pharmaceuticals International, plc's profit margins?
- Kiniksa Pharmaceuticals International, plc (KNSA) runs a 89.8% gross margin and a 11.9% operating margin, with a 9.6% net margin.
- Where do Kiniksa Pharmaceuticals International, plc's ratios come from?
- Every ratio is computed from Kiniksa Pharmaceuticals International, plc's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
